-
1 Comment
Spyder Cannabis Inc is currently in a long term downtrend where the price is trading 10.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.4.
Spyder Cannabis Inc's total revenue rose by 193.9% to $498K since the same quarter in the previous year.
Its net income has increased by 31.2% to $-176K since the same quarter in the previous year.
Finally, its free cash flow grew by 22.3% to $-153K since the same quarter in the previous year.
Based on the above factors, Spyder Cannabis Inc gets an overall score of 4/5.
| Exchange | V |
|---|---|
| CurrencyCode | CAD |
| ISIN | CA24713H1001 |
| Sector | Specialty Retail |
| Industry | Consumer Discretionary |
| Market Cap | 3M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | 0.0% |
| Beta | 3.06 |
Delota Corp. engages in the retail of various cannabis products in Canada and the United States. The company offers electronic cigarettes, cannabis supplies, e-juices, and accessories. As of June 10, 2021, it had retail operations in 26 locations across Ontario, as well as online operations. In addition, the company engages in the development of hemp-based products. The company was formerly known as Spyder Cannabis Inc. and changed its name to Delota Corp. in November 2021. Delota Corp. was founded in 2014 and is headquartered in Concord, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SPDR.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
